Meta-analyses of phase 3 randomised controlled trials of third generation aromatase inhibitors versus tamoxifen as first-line endocrine therapy in postmenopausal women with hormone receptor-positive advanced breast cancer-Reference-Cited by-同舟云学术

Meta-analyses of phase 3 randomised controlled trials of third generation aromatase inhibitors versus tamoxifen as first-line endocrine therapy in postmenopausal women with hormone receptor-positive advanced breast cancer

Published:2021-03 Issue: Volume:145 Page:19-28
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Robertson John. F.R.,Paridaens Robert J.,Lichfield Jasmine,Bradbury Ian,Campbell Christine

Funder

University of Nottingham

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database;Anderson;Breast Canc Res Treat,2002

2. A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474;Cole;Br J Canc,1971

3. Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial;Smith;Br Med J (Clin Res Ed),1981

4. A randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer;Lipton;Cancer,1982

5. Hormonal treatment for metastatic breast cancer: an Eastern Cooperative Oncology Group phase III trial comparing aminoglutethimide to tamoxifen;Gale;Cancer,1994

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A triple hormone receptor ER, AR, and VDR signature is a robust prognosis predictor in breast cancer;Breast Cancer Research;2024-09-13

2. Aromatase inhibitors: the journey from the state of the art to clinical open questions;Frontiers in Oncology;2023-12-22

3. Current Management and Future Perspectives of Hormone Receptor–Positive HER2-Negative Advanced Breast Cancer;Seminars in Oncology Nursing;2023-12

4. Anastrozole as a therapeutic option for gynecomastia in a person receiving antiretroviral therapy: Case report;British Journal of Clinical Pharmacology;2023-11-16

5. A review of tamoxifen administration regimen optimization for Cre/loxp system in mouse bone study;Biomedicine & Pharmacotherapy;2023-09